安旭生物
(688075)
| 流通市值：37.34亿 | | | 总市值：37.34亿 |
| 流通股本：1.27亿 | | | 总股本：1.27亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 188,856,165.18 | 71,198,925.07 | 451,255,115.98 | 325,286,887.42 |
| 营业总成本 | 282,842,949.33 | 120,853,303.06 | 531,110,941.6 | 392,903,928.66 |
| 其他经营收益 | | | | |
| 营业利润 | -17,228,971 | -14,166,776.45 | 69,571,675.93 | 58,752,253.78 |
| 利润总额 | -16,794,370.82 | -14,142,608.63 | 74,873,185.49 | 64,236,713.31 |
| 净利润 | -10,589,492.39 | -10,354,211.11 | 69,209,771.31 | 64,308,065.31 |
| 每股收益 | | | | |
| 其他综合收益 | -5,775,408.88 | -3,750,019.69 | -6,747,745.4 | -3,687,365.57 |
| 综合收益总额 | -16,364,901.26 | -14,104,230.8 | 62,462,025.91 | 60,620,699.74 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 4,635,793,905.9 | 4,700,919,069.3 | 4,591,874,325.42 | 4,629,730,923.04 |
| 非流动资产: | | | | |
| 非流动资产合计 | 1,080,866,310.92 | 1,057,157,905.21 | 1,084,693,310.23 | 1,013,854,212.12 |
| 资产总计 | 5,716,660,216.82 | 5,758,076,974.51 | 5,676,567,635.65 | 5,643,585,135.16 |
| 流动负债: | | | | |
| 流动负债合计 | 626,549,426.19 | 529,777,332.85 | 437,140,737.32 | 399,060,632.8 |
| 非流动负债: | | | | |
| 非流动负债合计 | 71,347,089.2 | 81,820,803.77 | 78,843,829.65 | 85,782,759.84 |
| 负债合计 | 697,896,515.39 | 611,598,136.63 | 515,984,566.97 | 484,843,392.64 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 5,022,735,272.97 | 5,150,496,453.97 | 5,164,606,490.92 | 5,162,604,172.76 |
| 股东权益合计 | 5,018,763,701.43 | 5,146,478,837.89 | 5,160,583,068.68 | 5,158,741,742.52 |
| 负债和股东权益合计 | 5,716,660,216.82 | 5,758,076,974.51 | 5,676,567,635.65 | 5,643,585,135.16 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 212,525,922.38 | 107,098,582.24 | 484,375,870.22 | 417,094,053.72 |
| 经营活动现金流出小计 | 248,048,779.33 | 110,173,257.96 | 493,783,035.77 | 415,911,615.7 |
| 经营活动产生的现金流量净额 | -35,522,856.95 | -3,074,675.72 | -9,407,165.55 | 1,182,438.02 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,689,727,601.22 | 3,045,035,308.03 | 10,691,007,122.28 | 8,825,768,809.02 |
| 投资活动现金流出小计 | 5,724,221,192.82 | 2,978,935,028.45 | 10,573,115,591.92 | 8,997,366,828.02 |
| 投资活动产生的现金流量净额 | -34,493,591.6 | 66,100,279.58 | 117,891,530.36 | -171,598,019 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 24,325,773.2 | - | 106,010,223.85 | 106,474,954.59 |
| 筹资活动产生的现金流量净额 | -24,325,773.2 | - | -106,010,223.85 | -106,474,954.59 |
| 汇率变动对现金及现金等价物的影响 | -5,228,009.43 | -1,729,883.08 | -40,655,864.92 | 349,671.9 |
| 现金及现金等价物净增加额 | -99,570,231.18 | 61,295,720.78 | -38,181,723.96 | -276,540,863.67 |
| 期末现金及现金等价物余额 | 320,531,723.01 | 481,397,674.97 | 420,101,954.19 | 181,742,814.48 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -99,570,231.18 | - | -38,181,723.96 | - |